Angela RubanCEO & Co-Founder at NeuroHagana LtdSpeaker
Profile
Dr. Angela Ruban holds a Ph.D. in Clinical Pharmacology and has dedicated the past two decades to advancing drug development for Central Nervous System (CNS) disorders. Her scientific expertise lies in elucidating the mechanisms of glutamate excitotoxicity and in developing therapeutic strategies for neurotrauma.
Dr. Ruban gained extensive experience in the drug development process through her roles as Chief Scientific Officer at Braintact Ltd. and as a Scientific Advisor at Yeda, the Technology Transfer Unit of the Weizmann Institute of Science. In 2015, she was appointed Principal Investigator at the Faculty of Medicine, Tel Aviv University, where she led pioneering research in emergency treatments for neurotrauma and CNS deseas.
Her research has been supported by prestigious foundations, including the U.S. Department of Defense, the Israel Ministry of Defense, the Wings for Life Foundation, and the Israel Innovation Authority.
In 2023, Dr. Ruban founded NeuroHagana Ltd., an innovative Israeli biotech start-up developing the first injectable emergency treatment designed to address all types and severities of neurotrauma.